RFK Jr.’s HHS Agenda: What Investigations into Antidepressants and Childhood Vaccines Mean for Pharma and Public Health
With Robert F. Kennedy Jr. now at the helm of the Department of Health and Human Services (HHS), his recent speech to agency staff marked the beginning of what could be a seismic shift in U.S. healthcare policy. Among his key initiatives: launching investigations into...
No More Data Silos: How TriNetX Uses Real-World Data to Pinpoint the Best Clinical Trial Sites
Combining disparate data sources to inform clinical trial site selection has long been a complex challenge. Inconsistent site naming, differences in the definition of a site, and a lack of potential patient counts, among other obstacles, have made it difficult for...
Unlock the Power of Harmonized Global Real-World Data: 5 Reasons to Partner with TriNetX
Real-world data (RWD) and the real-world evidence (RWE) derived from analysis of the data are a cornerstone of clinical advancements in today’s fast-paced research environment. However, integrating, harmonizing, and leveraging global datasets at scale presents...
Rewriting the Rules of Clinical Research with Real-World Data: 5 Shifts You Can’t Afford to Ignore
The healthcare and clinical research industries are undergoing a seismic shift. Rapid advancements in real-world data (RWD), artificial intelligence (AI), and patient-centric approaches are rewriting the playbook for clinical trials and treatment development. The...
Artificial Intelligence and Real-World Data: Speeding Up Drug Development Like Never Before
Clinical trials are vital to drug development but often face challenges such as slow patient recruitment, high costs, and suboptimal trial designs. Today, artificial intelligence (AI) and real-world data (RWD) are transforming this process by optimizing trial...
Diversity in Clinical Trials: The Ethical and Scientific Imperative to Bridge Health Disparities
In the evolving landscape of clinical research, the era of one-size-fits-all clinical trials is firmly behind us. Regulatory bodies and industry leaders alike recognize the necessity of diverse representation in trials to ensure that medical treatments are effective...
Advancing Multiple Myeloma Care: Insights from a Decade of Real-World Data in Europe
Multiple myeloma (MM) is a rare and complex blood cancer that affects plasma cells in the bone marrow. These malignant cells accumulate and interfere with normal blood cell production, leading to complications such as anemia, kidney dysfunction, bone lesions, and...
Network Spotlight: Hospital Sírio-Libanês
We are privileged to acknowledge Hospital Sírio-Libanês for their valuable collaboration with TriNetX. 1. Why did you join the TriNetX network? The Hospital Sírio-Libanês is a centennial institution dedicated to promoting integrated healthcare, teaching, and...